AG
LOXO

Artal Group’s Loxo Oncology, Inc LOXO Stock Holding History

Artal Group’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-65,000
Closed -$2.73M – 118
2017
Q1 		$2.73M Sell
65,000
-35,000
-35% -$1.44M 0.06% 78
2016
Q4 		$3.21M Buy
100,000
+25,000
+33% +$641K 0.07% 69
2016
Q3 		$1.96M Buy
+75,000
New +$1.96M 0.04% 84

Other funds holding LOXO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Artal Group's LOXO Position: Q2 2017 in Review

Artal Group sold out of Loxo Oncology, Inc (LOXO) in Q2 2017, closing a stake of 65,000 shares — an estimated $2.73M sold.

Artal Group first reported a position in LOXO in Q3 2016 and held it in 3 quarters. The position peaked at $3.21M in Q4 2016. 129 funds tracked by Wall St. Rank hold LOXO as of Q2 2017.

  • Artal Group reported no remaining Loxo Oncology, Inc position as of Q2 2017 after selling out during the quarter.
  • Artal Group sold 65,000 Loxo Oncology, Inc shares in Q2 2017, an estimated $2.73M.
  • Artal Group first reported a position in Loxo Oncology, Inc in Q3 2016 and held it in 3 quarters.
  • Artal Group's Loxo Oncology, Inc position peaked at $3.21M in Q4 2016.
  • 129 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q2 2017.

Based on Artal Group's 13F filing for Q2 2017, filed 11 Aug 2017.